Explore the vast range of titles available.

Deep learning (DL) based solutions have been proposed for interpretation of several imaging modalities including radiography, CT, and MR. For chest radiographs, DL algorithms have found success in the evaluation of abnormalities such as lung nodules, pulmonary tuberculosis, cystic fibrosis, pneumoconiosis, and location of peripherally inserted central catheters. Chest radiography represents the most commonly performed radiological test for a multitude of non-emergent and emergent clinical indications. This study aims to assess accuracy of deep learning (DL) algorithm for detection of abnormalities on routine frontal chest radiographs (CXR), and assessment of stability or change in findings over serial radiographs. We processed 874 de-identified frontal CXR from 724 adult patients (> 18 years) with DL (Qure AI). Scores and prediction statistics from DL were generated and recorded for the presence of pulmonary opacities, pleural effusions, hilar prominence, and enlarged cardiac silhouette. To establish a standard of reference (SOR), two thoracic radiologists assessed all CXR for these abnormalities. Four other radiologists (test radiologists), unaware of SOR and DL findings, independently assessed the presence of radiographic abnormalities. A total 724 radiographs were assessed for detection of findings. A subset of 150 radiographs with follow up examinations was used to asses change over time. Data were analyzed with receiver operating characteristics analyses and post-hoc power analysis. About 42% (305/ 724) CXR had no findings according to SOR; single and multiple abnormalities were seen in 23% (168/724) and 35% (251/724) of CXR. There was no statistical difference between DL and SOR for all abnormalities (p = 0.2-0.8). The area under the curve (AUC) for DL and test radiologists ranged between 0.837-0.929 and 0.693-0.923, respectively. DL had lowest AUC (0.758) for assessing changes in pulmonary opacities over follow up CXR. Presence of chest wall implanted devices negatively affected the accuracy of DL algorithm for evaluation of pulmonary and hilar abnormalities. DL algorithm can aid in interpretation of CXR findings and their stability over follow up CXR. However, in its present version, it is unlikely to replace radiologists due to its limited specificity for categorizing specific findings.

To compare the performance of artificial intelligence (AI) and Radiographic Assessment of Lung Edema (RALE) scores from frontal chest radiographs (CXRs) for predicting patient outcomes and the need for mechanical ventilation in COVID-19 pneumonia. Our IRB-approved study included 1367 serial CXRs from 405 adult patients (mean age 65 ± 16 years) from two sites in the US (Site A) and South Korea (Site B). We recorded information pertaining to patient demographics (age, gender), smoking history, comorbid conditions (such as cancer, cardiovascular and other diseases), vital signs (temperature, oxygen saturation), and available laboratory data (such as WBC count and CRP). Two thoracic radiologists performed the qualitative assessment of all CXRs based on the RALE score for assessing the severity of lung involvement. All CXRs were processed with a commercial AI algorithm to obtain the percentage of the lung affected with findings related to COVID-19 (AI score). Independent t- and chi-square tests were used in addition to multiple logistic regression with Area Under the Curve (AUC) as output for predicting disease outcome and the need for mechanical ventilation. The RALE and AI scores had a strong positive correlation in CXRs from each site (r 2  = 0.79–0.86; p  < 0.0001). Patients who died or received mechanical ventilation had significantly higher RALE and AI scores than those with recovery or without the need for mechanical ventilation ( p  < 0.001). Patients with a more substantial difference in baseline and maximum RALE scores and AI scores had a higher prevalence of death and mechanical ventilation ( p  < 0.001). The addition of patients’ age, gender, WBC count, and peripheral oxygen saturation increased the outcome prediction from 0.87 to 0.94 (95% CI 0.90–0.97) for RALE scores and from 0.82 to 0.91 (95% CI 0.87–0.95) for the AI scores. AI algorithm is as robust a predictor of adverse patient outcome (death or need for mechanical ventilation) as subjective RALE scores in patients with COVID-19 pneumonia.

Mechanical thrombectomy (MT) eligibility for acute ischemic stroke (AIS) patients depends upon clinical and advanced imaging assessments like CT perfusion (CTP). Assessment complexities and limited access to advanced imaging investigations are known challenges. We developed machine-learning models using routinely collected clinical and imaging data to predict MT eligibility. Age, National-Institutes-of-Health-Stroke-Scale-Score (NIHSS), last-known-well-time (LKWT), noncontrast-CT (NCCT) scan and CT-angiography (CTA) report from consecutive cohort of 260 AIS-suspected patients treated at a stroke centre during Apr'20 to Dec'23 were retrospectively collected. 160 underwent MT for anterior-circulation large vessel occlusion (LVOa); rest were MT ineligible. MT eligibility was determined based on clinical and imaging investigations including CTP during routine-care. The dataset was split into train:test sets (50:50 split). A commercially available artificial-intelligence algorithm calculated infarct volume and ASPECT score (ASPECTSq) from the NCCTs. We developed two supervised models using Gradient-Boosting-Machines. MODEL1 utilized age, NIHSS, LKWT, ASPECTSq and infarct volume as inputs; MODEL2 additionally included the presence/absence of LVOa as input. The target/response variable used for our supervised learning methods was whether the patients were MT eligible or not as determined during routine-care. Performance of the models were investigated using the test set. Among 130 patients (mean age ± standard-deviation: 67.4 ± 14.2 years; 61 males) in test set, 80 (61.5%) were MT eligible; rest were ineligible. The area-under-the-receiver-operating-characteristics-curve, sensitivity and specificity of MODEL1 were 0.76 (95% CI: 0.67-0.85), 85% (75.6-91.2) and 60% (46.2-72.4), respectively. They were 0.92 (0.88-0.96), 82.5% (72.7-89.3) and 82% (69.2-90.2), respectively, for MODEL2. The models showed promising results, demonstrating that NCCT, potentially with CTA, could be sufficient for MT eligibility determination. Such models can enable faster referrals of patients to higher centers.

In medical practice, chest X-rays are the most ubiquitous diagnostic imaging tests. However, the current workload in extensive health care facilities and lack of well-trained radiologists is a significant challenge in the patient care pathway. Therefore, an accurate, reliable, and fast computer-aided diagnosis (CAD) system capable of detecting abnormalities in chest X-rays is crucial in improving the radiological workflow. In this prospective multicenter quality-improvement study, we have evaluated whether artificial intelligence (AI) can be used as a chest X-ray screening tool in real clinical settings. Methods: A team of radiologists used the AI-based chest X-ray screening tool (qXR) as a part of their daily reporting routine to report consecutive chest X-rays for this prospective multicentre study. This study took place in a large radiology network in India between June 2021 and March 2022. Results: A total of 65,604 chest X-rays were processed during the study period. The overall performance of AI achieved in detecting normal and abnormal chest X-rays was good. The high negatively predicted value (NPV) of 98.9% was achieved. The AI performance in terms of area under the curve (AUC), NPV for the corresponding subabnormalities obtained were blunted CP angle (0.97, 99.5%), hilar dysmorphism (0.86, 99.9%), cardiomegaly (0.96, 99.7%), reticulonodular pattern (0.91, 99.9%), rib fracture (0.98, 99.9%), scoliosis (0.98, 99.9%), atelectasis (0.96, 99.9%), calcification (0.96, 99.7%), consolidation (0.95, 99.6%), emphysema (0.96, 99.9%), fibrosis (0.95, 99.7%), nodule (0.91, 99.8%), opacity (0.92, 99.2%), pleural effusion (0.97, 99.7%), and pneumothorax (0.99, 99.9%). Additionally, the turnaround time (TAT) decreased by about 40.63% from pre-qXR period to post-qXR period. Conclusions: The AI-based chest X-ray solution (qXR) screened chest X-rays and assisted in ruling out normal patients with high confidence, thus allowing the radiologists to focus more on assessing pathology on abnormal chest X-rays and treatment pathways.

Background: The chest radiograph (CXR) is the most frequently performed radiological examination worldwide. The increasing volume of CXRs performed in hospitals causes reporting backlogs and increased waiting times for patients, potentially compromising timely clinical intervention and patient safety. Implementing computer-aided detection (CAD) artificial intelligence (AI) algorithms capable of accurate and rapid CXR reporting could help address such limitations. A novel use for AI reporting is the classification of CXRs as ‘abnormal’ or ‘normal’. This classification could help optimize resource allocation and aid radiologists in managing their time efficiently. Methods: qXR is a CE-marked computer-aided detection (CAD) software trained on over 4.4 million CXRs. In this retrospective cross-sectional pre-deployment study, we evaluated the performance of qXR in stratifying normal and abnormal CXRs. We analyzed 1040 CXRs from various referral sources, including general practices (GP), Accident and Emergency (A&E) departments, and inpatient (IP) and outpatient (OP) settings at East Kent Hospitals University NHS Foundation Trust. The ground truth for the CXRs was established by assessing the agreement between two senior radiologists. Results: The CAD software had a sensitivity of 99.7% and a specificity of 67.4%. The sub-group analysis showed no statistically significant difference in performance across healthcare settings, age, gender, and X-ray manufacturer. Conclusions: The study showed that qXR can accurately stratify CXRs as normal versus abnormal, potentially reducing reporting backlogs and resulting in early patient intervention, which may result in better patient outcomes.

Purpose: We assessed whether a CXR AI algorithm was able to detect missed or mislabeled chest radiograph (CXR) findings in radiology reports. Methods: We queried a multi-institutional radiology reports search database of 13 million reports to identify all CXR reports with addendums from 1999–2021. Of the 3469 CXR reports with an addendum, a thoracic radiologist excluded reports where addenda were created for typographic errors, wrong report template, missing sections, or uninterpreted signoffs. The remaining reports contained addenda (279 patients) with errors related to side-discrepancies or missed findings such as pulmonary nodules, consolidation, pleural effusions, pneumothorax, and rib fractures. All CXRs were processed with an AI algorithm. Descriptive statistics were performed to determine the sensitivity, specificity, and accuracy of the AI in detecting missed or mislabeled findings. Results: The AI had high sensitivity (96%), specificity (100%), and accuracy (96%) for detecting all missed and mislabeled CXR findings. The corresponding finding-specific statistics for the AI were nodules (96%, 100%, 96%), pneumothorax (84%, 100%, 85%), pleural effusion (100%, 17%, 67%), consolidation (98%, 100%, 98%), and rib fractures (87%, 100%, 94%). Conclusions: The CXR AI could accurately detect mislabeled and missed findings. Clinical Relevance: The CXR AI can reduce the frequency of errors in detection and side-labeling of radiographic findings.

The opportunistic use of radiological examinations for disease detection can potentially enable timely management. We assessed if an index created by an AI software to quantify chest radiography (CXR) findings associated with heart failure (HF) could distinguish between patients who would develop HF or not within a year of the examination. Our multicenter retrospective study included patients who underwent CXR without an HF diagnosis. We included 1117 patients (age 67.6 ± 13 years; m:f 487:630) that underwent CXR. A total of 413 patients had the CXR image taken within one year of their HF diagnosis. The rest (n = 704) were patients without an HF diagnosis after the examination date. All CXR images were processed with the model (qXR-HF, Qure.AI) to obtain information on cardiac silhouette, pleural effusion, and the index. We calculated the accuracy, sensitivity, specificity, and area under the curve (AUC) of the index to distinguish patients who developed HF within a year of the CXR and those who did not. We report an AUC of 0.798 (95%CI 0.77–0.82), accuracy of 0.73, sensitivity of 0.81, and specificity of 0.68 for the overall AI performance. AI AUCs by lead time to diagnosis (<3 months: 0.85; 4–6 months: 0.82; 7–9 months: 0.75; 10–12 months: 0.71), accuracy (0.68–0.72), and specificity (0.68) remained stable. Our results support the ongoing investigation efforts for opportunistic screening in radiology.

Background: Missed findings in chest X-ray interpretation are common and can have serious consequences. Methods: Our study included 2407 chest radiographs (CXRs) acquired at three Indian and five US sites. To identify CXRs reported as normal, we used a proprietary radiology report search engine based on natural language processing (mPower, Nuance). Two thoracic radiologists reviewed all CXRs and recorded the presence and clinical significance of abnormal findings on a 5-point scale (1—not important; 5—critical importance). All CXRs were processed with the AI model (Qure.ai) and outputs were recorded for the presence of findings. Data were analyzed to obtain area under the ROC curve (AUC). Results: Of 410 CXRs (410/2407, 18.9%) with unreported/missed findings, 312 (312/410, 76.1%) findings were clinically important: pulmonary nodules (n = 157), consolidation (60), linear opacities (37), mediastinal widening (21), hilar enlargement (17), pleural effusions (11), rib fractures (6) and pneumothoraces (3). AI detected 69 missed findings (69/131, 53%) with an AUC of up to 0.935. The AI model was generalizable across different sites, geographic locations, patient genders and age groups. Conclusion: A substantial number of important CXR findings are missed; the AI model can help to identify and reduce the frequency of important missed findings in a generalizable manner.

Deep learning-based automated diagnosis of lung cancer has emerged as a crucial advancement that enables healthcare professionals to detect and initiate treatment earlier. However, these models require extensive training datasets with diverse case-specific properties. High-quality annotated data is particularly challenging to obtain, especially for cases with subtle pulmonary nodules that are difficult to detect even for experienced radiologists. This scarcity of well-labeled datasets can limit model performance and generalization across different patient populations. Digitally reconstructed radiographs (DRR) using CT-Scan to generate synthetic frontal chest X-rays with artificially inserted lung nodules offers one potential solution. However, this approach suffers from significant image quality degradation, particularly in the form of blurred anatomical features and loss of fine lung field structures. To overcome this, we introduce DiffusionXRay, a novel image restoration pipeline for Chest X-ray images that synergistically leverages denoising diffusion probabilistic models (DDPMs) and generative adversarial networks (GANs). DiffusionXRay incorporates a unique two-stage training process: First, we investigate two independent approaches, DDPM-LQ and GAN-based MUNIT-LQ, to generate low-quality CXRs, addressing the challenge of training data scarcity, posing this as a style transfer problem. Subsequently, we train a DDPM-based model on paired low-quality and high-quality images, enabling it to learn the nuances of X-ray image restoration. Our method demonstrates promising results in enhancing image clarity, contrast, and overall diagnostic value of chest X-rays while preserving subtle yet clinically significant artifacts, validated by both quantitative metrics and expert radiological assessment.

Early detection of lung cancer in chest radiographs (CXRs) is crucial for improving patient outcomes, yet nodule detection remains challenging due to their subtle appearance and variability in radiological characteristics like size, texture, and boundary. For robust analysis, this diversity must be well represented in training datasets for deep learning based Computer-Assisted Diagnosis (CAD) systems. However, assembling such datasets is costly and often impractical, motivating the need for realistic synthetic data generation. Existing methods lack fine-grained control over synthetic nodule generation, limiting their utility in addressing data scarcity. This paper proposes a novel diffusion-based framework with low-rank adaptation (LoRA) adapters for characteristic controlled nodule synthesis on CXRs. We begin by addressing size and shape control through nodule mask conditioned training of the base diffusion model. To achieve individual characteristic control, we train separate LoRA modules, each dedicated to a specific radiological feature. However, since nodules rarely exhibit isolated characteristics, effective multi-characteristic control requires a balanced integration of features. We address this by leveraging the dynamic composability of LoRAs and revisiting existing merging strategies. Building on this, we identify two key issues, overlapping attention regions and non-orthogonal parameter spaces. To overcome these limitations, we introduce a novel orthogonality loss term during LoRA composition training. Extensive experiments on both in-house and public datasets demonstrate improved downstream nodule detection. Radiologist evaluations confirm the fine-grained controllability of our generated nodules, and across multiple quantitative metrics, our method surpasses existing nodule generation approaches for CXRs.